FDA budget not in stone yet

It's never enough. The Alliance for a Stronger FDA is "disappointed" in the president's 23 percent budget increase request and will seek to increase it from tax revenues, which are a shrinking source of FDA funds. User fees, by contrast, have mushroomed to $1.5 billion for 2011--up from a mere $369 million in 2006. Article

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)